Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001179110-17-006246

President and CEO bought 23,810 shares at $2.10 ($50,001)

From the SEC's structured data for this filing

Trades in this filing

Kumar Ramesh · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-04-26 Purchase : show line 1 in the form +23,810 $2.10 $50,001 102,227 D
Open-market purchases · 23,810 sh · avg $2.10 · $50,001
Loading xslF345X03/edgar.xml…